arrow_back Back Filing freshness 10-Q SEC EDGAR

Hemab Therapeutics Holdings, Inc.

COAG
$49.50 ▼ -2.56 (-4.92%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
0 Visible periods
0 Metrics
Peer-ranked Benchmarks
Price Chart
insights
Verdict pending

Sync financial data to generate a health grade for this company.

auto_awesome

Analytical Summary

Review the statement evidence below to form a view on COAG.

Market Cap
Dividend Yield
Revenue Growth
Op. Margin
ROIC
FCF / Share
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago